Catherine Skari

Guidelines for the Management of Non-Transfusion-Dependent β-Thalassaemia (3rd edition – 2023)

Ali T. Taher, MD PhD FRCP Khaled M. Musallam, MD PhD Maria Domenica Cappellini, MD FACP

Read More »

Gene Therapy for β-Hemoglobinopathies: From Discovery to Clinical Trials

Beta thalassaemia is an inherited disorder that impairs the production of haemoglobin, the blood protein responsible for transporting oxygen. Patients…

Read More »

Increased Risk of Venous Thromboembolism in Splenectomized Patients with Sickle Cell Disease

Sickle cell disease (SCD) patients may need to have their spleen removed due to various conditions related to their health…

Read More »

NEW PUBLICATION | Guidelines for the Management of Non-Transfusion-Dependent β-Thalassaemia

This novel edition is an invaluable contribution in upgrading the care of individuals with NTDT, a condition that has been…

Read More »

8 MAY | International Thalassaemia Day 2023

Read More »

G6PD | Common Enzyme Deficiency Linked with COVID Severity

In Black men under 65, for example, those with the common enzyme deficiency had a roughly 1.5-fold higher risk for…

Read More »

TIF’s Executive Director Chosen Among ‘Women Who Advance Associations 2023′

‘Women Who Advance Associations’ celebrates the great talent of the international association community. For International Women’s Day, marked annually on…

Read More »

INTERNATIONAL THALASSAEMIA DAY 2023 | The Official Page Is Now Live!

  Head to the official webpage https://thalassaemia.org.cy/itd2023/ to explore the fantastic International Thalassaemia Day resources and activities, learn more about…

Read More »

Deferiprone for Transfusional Iron Overload in Sickle Cell Disease and Other Anemias: Open-label Study of Up to 3 Years

Long-term safety and efficacy data on the iron chelator deferiprone in sickle cell disease (SCD) and other anemias are limited.…

Read More »

Expecting More: The Case for Incorporating Fertility Services into Comprehensive Sickle Cell Disease Care

In recent years, advances in the medical care of sickle cell disease including optimal blood transfusion, the use of hydroxyurea…

Read More »